1. Home
  2. BESS vs RGNT Comparison

BESS vs RGNT Comparison

Compare BESS & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bimergen Energy Corporation Common Stock

BESS

Bimergen Energy Corporation Common Stock

N/A

Current Price

$2.91

Market Cap

16.8M

Sector

N/A

ML Signal

N/A

Logo Regentis Biomaterials Ltd. Ordinary Shares

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$1.26

Market Cap

14.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BESS
RGNT
Founded
1998
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.8M
14.3M
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
BESS
RGNT
Price
$2.91
$1.26
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $8.50
N/A
AVG Volume (30 Days)
★ 268.8K
37.3K
Earning Date
11-13-2026
09-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $168,880.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$206.88
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.52
$1.16
52 Week High
$6.45
$15.50

Technical Indicators

Market Signals
Indicator
BESS
RGNT
Relative Strength Index (RSI) 52.82 38.60
Support Level $2.75 $1.21
Resistance Level $3.17 $2.52
Average True Range (ATR) 0.45 0.15
MACD 0.09 0.01
Stochastic Oscillator 42.81 16.21

Price Performance

Historical Comparison
BESS
RGNT

About BESS Bimergen Energy Corporation Common Stock

Bimergen Energy Corp is a renewable energy project developer that enables the clean energy transition and provides critical grid stability via solutions across a range of applications through portfolio of utility-scale Battery Energy Storage System (BESS) and solar development projects. Its portfolio includes approximately 23 development-stage utility-scale BESS projects with a projected total storage capacity of around 1.965 gigawatts (GW) and approximately 13 development-stage solar energy projects expected to generate around 1.640 GW upon completion and operation.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: